Skip to main navigation
Skip to search
Skip to main content
Augusta University Research Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Grants
Scholarly Output
Datasets
Activities
Prizes
Search by expertise, name or affiliation
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
SONAR Committees and Investigators
Nephrology
Research output
:
Contribution to journal
›
Article
›
peer-review
396
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Atrasentan
100%
Chronic Renal Insufficiency
54%
Type 2 Diabetes Mellitus
44%
Placebos
40%
Randomized Controlled Trials
40%
Kidney
31%
Endothelin Receptor Antagonists
15%
Creatinine
14%
Psychology Retention
13%
Glomerular Filtration Rate
11%
Chronic Kidney Failure
10%
Albumins
10%
Endothelin A Receptor Antagonists
8%
Urine
8%
Albuminuria
6%
Safety
6%
Body Surface Area
6%
Double-Blind Method
5%
Kidney Transplantation
5%
Intention
5%
Renal Insufficiency
5%
Dialysis
5%
Anemia
4%
Sodium
4%
Therapeutics
4%
Psychological Inhibition
4%
Heart Failure
4%
Research Personnel
4%
Serum
2%
Population
2%